Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CEROW will - over the next 2 Weeks and hit - by . In that time frame, CEROW's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
CEROW shares fell -29.49% in Friday, September 4, 2026's trading session, dropping from a previous close of $0.00 to move at $0.00. The stock demonstrated notable intraday movement (see CEROW's key stats for a full breakdown), fluctuating between $0.00 and $0.00, a +129.41% trading range. While recent weeks have seen some volatility, CEROW has managed to secure a +61.76% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 4.93K shares changing hands, 4.92K more than the previous session. This amounted to $13.54 in total market activity.
Will CEROW Continue Its Trend?
According to analyst ratings and projections for CEROW, CERo Therapeutics Holdings, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for CEROW currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the CEROW stock forecast, now is not the best time to buy CEROW stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on CEROW covering social and institutional perspectives.
CEROW Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CEROW's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.05% to 48.45%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.63%, maintains a neutral outlook for the long term. Insights into CEROW's shareholder base show how institutional investors are positioning themselves during these momentum shifts

